Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Vascular Surgery|July 6, 2000
Atheroemboli to the brain: size threshold for causing acute neuronal cell deathJ H Rapp, X M Pan, F R Sharp, et al.Journal of Medicinal Chemistry|May 1, 1986
Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinoneD W Robertson, E E Beedle, J K Swartzendruber, et al.Life Sciences|January 1, 1995
(R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptakeD R Gehlert, S K Hemrick-Luecke, D A Schober, et al.Neurochemistry International|January 1, 1995
Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brainD R Gehlert, D A Schober, S K Hemrick-Luecke, et al.Bioorganic & Medicinal Chemistry Letters|December 4, 2003
Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptakeF P Bymaster, E E Beedle, J Findlay, et al.Cancer Research|September 1, 1992
Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinomaB L Neubauer, K L Best, R L Goode, et al.Bioorganic & Medicinal Chemistry|September 1, 2000
The discovery of 4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1 ,5-a]-pyrimidine: a corticotropin-releasing factor (hCRF1) antagonistP J Gilligan, C Baldauf, A Cocuzza, et al.Molecular Pharmacology|January 5, 2000
Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramineL W Fitzgerald, T C Burn, B S Brown, et al.The Journal of Biological Chemistry|August 1, 2000
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitorsD Seiffert, J D Bradley, C M Rominger, et al.Human Molecular Genetics|June 15, 2001
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsS L Roberds, J Anderson, G Basi, et al.Pageof 9